Want to join the conversation?
$JNJ's Alios BioPharma said new data published in New England Journal of Medicine shows potential of compound to fight respiratory syncytial virus (RSV) infection. This Phase 2a study now established human proof-of-concept for antiviral activity of ALS-008176 in healthy adults and highlights potential as therapy for managing clinical disease.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!